Table 2 Adjusted odds ratio (OR) of the probability of gametocyte prevalence, using a multivariate random effect logistic model for untreated and SP-treated children separately.
From: Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya
Risk factors for gametocytaemia | Adjusted OR (95% CI) | ||
|---|---|---|---|
No treatment | Treatment with SP | ||
Day of follow-up | Day 7 | 1.48 (0.62 – 3.56)¥ | 1.77 (0.93–3.34)¥ |
Day 14 | 1 (ref) | 1 (ref) | |
Age | <5 years | 6.34 (1.15–34.90) | 5.38 (1.91–15.17) |
5–9 years | 3.07 (0.98–9.55)¥ | 3.22 (1.19–8.72) | |
10–16 years | 1 (ref) | 1 (ref) | |
Asexual parasite density at enrolment | Per 100 parasites/μl | 1.05 (1.00–1.11) | 1.01 (1.00–1.01) |
Gametocyte prevalence at enrolment | Present | 3.35 (1.22–9.18) | 4.12 (2.11–8.02) |
Absent | 1 (ref) | 1 (ref) | |
SP treatment outcome | R2/3 resistance | - | 3.40 (1.61–7.19) |
Rl resistance | - | 1.06 (0.45–2.47)¥ | |
Adequate response | - | 1 (ref) | |